Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Brompheniramine recalled?

Not under an active recall. Brompheniramine was recalled 8 times in the past — all now closed. Most recent: Mar 15, 2021.

Most common reason: Sterility / contamination (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Brompheniramine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Brompheniramine recalls on record

none so far in 2026; 8 on record, newest first
Class II · Moderate risk

Brompheniramine Maleate

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 60432-275-16 D-0596-2021
Class II · Moderate risk

Brompheniramine Maleate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3019-07 D-0243-2016
Class III · Low risk

Poly-Tussin Ac Liquid

Does Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording "Rx Only".

Terminated Unapproved drug Poly Pharmaceuticals, Inc D-1431-2014
Class II · Moderate risk

Brompheniramine 10ml

The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.

Terminated Other Main Street Family Pharmacy, LLC D-064-2014